| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| Gene symbol | CD38 | Synonyms | ADPRC 1, ADPRC1, cADPR1 | Type of gene | protein-coding |
| Chromosome | 4 | Map location | 4p15.32 | dbXrefs | |
| Gene perturbation-related omics dataset | PertOrg | ||||
| Description | CD38 molecule | ||||
| GTO ID | GTC0858 |
| Trial ID | ChiCTR2000032501 |
| Disease | Multiple Myeloma |
| Altered gene | BCMA|CD38 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | BCMA/CD38 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | An open single center single arm clinical study of through infusion of anti-BCMA CAR-T and anti-CD38 CAR-T therapy for relapsed and refractory multiply myeloma |
| Year | 2020 |
| Country | China |
| Company sponsor | Affiliated Hospital of Xuzhou Medical University |
| Cohort 1 | |||||||
|
|||||||